Meds Cost Lives
#MultiplyChange
NextGen Leaders
Historic bill to stop price-gouging on drugs becomes law in Maryland
by Da-Yae Lee | May 26, 2017
Maryland becomes the first state to pass a bill prohibiting drug price hikes
by Da-Yae Lee | April 27, 2017
Congratulations to YP-CDN Baltimore for helping Maryland become the first U.S. state to pass a bill prohibiting drug price hikes
April 10 was a historic day in the fight for drug price transparency and affordability in the U.S.! With the House voting 137-2 and the Senate 38-7, Maryland passed a first-of-the-nation bill (HB 631/SB 415) that bans pharmas' price-gouging on generic and off-patent drugs. The bill achieves this by allowing the state attorney to sue drug makes that sharply raise prices.
We're proud to say YP-CDN Baltimore Chapter was directly involved in community organizing and advocacy efforts that contributed to this historic feat! Activities included growing the statewide coalition, calling legislators and key constituents, creating infographics and fact-sheets to explain key concepts to legislators, meeting with legislators and legislative staff in Annapolis, and testifying at hearings and work-groups.
Congratulations and thank you, YP-CDN Baltimore, for your work toward this feat!
Read more coverage around the web:
Reuters / Huffington Post / Washington's Top News / Baltimore Sun
The True Price of High Drug Costs
by Hussain Lalani | February 13, 2017
As a future physician, I will be unable to fulfill my Hippocratic duty if patients can't afford the drugs I prescribe to heal them.
Transparency in Drug Pricing: The Facts
Prescription Drug Pricing: The Facts
YP-Baltimore celebrated Advocacy Day!
On Thursday Feb. 2, 2017, members of YP-Baltimore participated in Advocacy Day hosted by the Maryland American Heart Association in Annapolis, MD. We met with our Senators and Delegates and advocated for the Prescription Drug Affordability Initiative. For some of us, this was our first time in Annapolis, and we experienced what it's like to converse with legislators who make important policy decisions on behalf of all Marylanders.
Although residents have the right to meet with legislators to share their experiences and to communicate their feelings on important issues, only a select percentage are able to do so every year. So, we were glad to have this precious opportunity to speak face-to-face with legislators.
We came out of this event not only enriched in our understanding of important contexts surrounding issues currently on the policy table but also motivated to continue the advocacy efforts as campaigns heat up!
Senate Finance Committee: Briefing on Prescription Drug Pricing in Annapolis, MD
On January 24, YP-Baltimore chapter leaders Hussain and Minzhi attended a briefing in Annapolis, MD, which was called by the Senate Finance Committee to discuss more about the pricing of prescription drugs.
Key stakeholders were present, including leaders from Pharmaceutical Research and Manufactures Association of America (PhRMA), CareFirst Blue Cross Blue Shield, Pharmaceutical Care Management Association (leader of 12 pharmaceutical benefit managers), research professors from Johns Hopkins, Institute for Clinical and Economic Review, and the Special Assistant from the Office of the Attorney General. There were four panels with two to four experts. Each expert made a brief presentation related to their perspective on prescription drug pricing and raised discussion on key challenges and recommendations.
Senate Finance Committee - Jan 24, 2017: Briefing on Prescription Drug Pricing
Publications Advocacy Cancer Cardiovascular Mental Health Diabetes Essential Medicines Access to Treatment Statements Trainings Africa North America Publications Advocacy Cancer Cardiovascular Mental Health Diabetes Essential Medicines Access to Treatment Statements Trainings Africa North America
by Da-Yae Lee | March 20, 2017
Op-Eds & Blogs
We provide a voice for young professionals at the global level. We believe young people are a central catalyst for the emergence of new ideas to confront the challenge of NCDs.
Open Letter Supporting Italy's Proposed Resolution on Improving the Transparency of Markets for Drugs, Vaccines and other Health-related Technologies
Level of adherence to dietaryrecommendations and barriers among type2 diabetic patients
Letter to the co-Chairs of the UN High-Level Meeting on NCDs: A call to strong commitments to human rights and affordable medicines and technologies
Board of Directors Recruitment 2017
© Young Professionals Chronic Disease Network
Read the blog at Young Professionals Chronic Disease Network